CN Stock MarketDetailed Quotes

Chongqing Lummy Pharmaceutical (300006)

Watchlist
  • 6.39
  • -0.05-0.78%
Market Closed Apr 30 15:00 CST
6.75BMarket Cap-49.53P/E (TTM)

Chongqing Lummy Pharmaceutical (300006) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Specialty category292.43M37.70%
Large infusion class202.97M26.17%
Pharmaceutical circulation152.16M19.62%
Anti-infective class78.54M10.13%
Service income19.08M2.46%
Other varieties16.77M2.16%
Other business13.73M1.77%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing590.72M76.15%
Pharmaceutical circulation152.16M19.62%
Service income19.08M2.46%
Other business13.73M1.77%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Central China224.16M28.90%
Southwest area214.4M27.64%
East China region114.21M14.72%
South China71.86M9.26%
North China60.44M7.79%
Northeast area44.45M5.73%
Northwest region32.44M4.18%
Other business13.73M1.77%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More